| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |